Home›Stock Screener›Neochem Bio Solutions›Financial Statements

Neochem Bio Solutions Complete Financial Statements

3 Years of Data
2025 - 2023

In FYNone, Neochem Bio Solutions (NEOCHEM) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of 9.3% and ROE of 40.0%. Full financial statements from FY2023 to FY2025 (3 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. View NEOCHEM annual price range for the annual high/low range and current price position.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 9.30% 2025 data
EBITDA Margin 17.44% 2025 data
Operating Margin 16.00% 2025 data
Return on Assets 10.13% 2025 data
Return on Equity 40.00% 2025 data

Balance Sheet Ratios

Current Ratio 3.53 2025 data
Equity Ratio 25.32% 2025 data
Asset Turnover 1.09 2025 data

NEOCHEM Revenue, Net Profit & EBITDA — Year-on-Year Growth

NEOCHEM YoY (March 2025 vs Period) — revenue -100.0%, net profit -100.0%, EBITDA -100.0%, expenses -100.0%. For live price, earnings ratios and company overview, see NEOCHEM share price screener.

Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+23.4%
Year-over-Year
Equity Growth
+66.7%
Year-over-Year
Operating Cash Flow Growth
+50.0%
Year-over-Year
Investing Cash Flow Growth
+75.0%
Year-over-Year
Financing Cash Flow Growth
-116.7%
Year-over-Year

NEOCHEM Income Statement — Revenue, EBITDA & Net Profit

Neochem Bio Solutions revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin 9.3%. Check Neochem Bio Solutions market worth to track the company's total market size over time.

Periods ₹ Crores
Particulars None March 2025 March 2024
Revenue 0 86 62
Expenses 0 71 55
EBITDA 0 15 7
Operating Profit Margin % 0.00% 16.00% 10.00%
Depreciation 0 1 1
Interest 0 4 3
Profit Before Tax 0 10 3
Tax 0 3 1
Net Profit 0 8 2
Earnings Per Share (₹) 0.00 6.64 1.90

NEOCHEM Balance Sheet — Assets, Liabilities & Shareholders' Equity

NEOCHEM total assets ₹79 Cr, total equity ₹20 Cr, total liabilities ₹ Cr (2025) — ROE 40.0%.

Years Annual Data ₹ Crores
Particulars 2025 2024
ASSETS
Total Assets 79 64
Current Assets 53 39
Fixed Assets 19 19
Capital Work in Progress 0 0
Investments 0 0
Other Assets 60 45
LIABILITIES
Total Liabilities
Current Liabilities 15 19
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 20 12
Share Capital 7 7
Reserves & Surplus 13 5

NEOCHEM Cash Flow Statement — Operating, Investing & Financing

Neochem Bio Solutions operating cash flow ₹3 Cr, investing ₹-2 Cr, financing ₹-1 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023
Operating Activities 3 2 -1
Investing Activities -2 -8 -3
Financing Activities -1 6 4
Net Cash Flow 0 0 0